Activation of peroxisome proliferator-activated receptor γ by troglitazone inhibits cell growth through the increase of p27(Kip1) in human pancreatic carcinoma cells

Cancer Research

Volumn 60, Issue 19, 2000, Pages 5558-5564

  Motomura, W ^a   Okumura, T ^a   Takahashi, N ^a   Obara, T ^a   Kohgo, Y ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P27; TROGLITAZONE;

ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CELL DIVISION; CHROMANS; G1 PHASE; GROWTH INHIBITORS; HUMAN; IMMUNOHISTOCHEMISTRY; LUCIFERASE; MICROTUBULE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; PEROXISOME PROLIFERATORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; THIAZOLES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034306992     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Epidemiology and risk factors in pancreatic cancer
2. Pancreatic carcinoma
3. The nuclear receptor superfamily: The second decade
4. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
5. Adipogenesis and obesity: Rounding out the big picture
6. Differentiation and reversal of malignant changes in colon cancer through PPARγ
7. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells
8. Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells
9. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6JAPC(min)/+mice
10. Activation of the nuclear PPARγ enhances colon polyp formation
11. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
12. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
13. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
14. Terminal differentiation of human breast cancer through PPARγ
15. Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells
16. Hypolipidemic drugs, polyunsaturated fatty acid, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
17. Fatty acids and eicosanoids regulate gene expression through direct interaction with peroxisome proliferator-activated receptor α and γ
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Tissue distribution and quantification of the expression of mRNAs of proliferator-activated receptors and liver X receptor-α in humans
20. Identification of an extended half-site motif required for the function of peroxisome proliferator-activated receptor α
21. Regulation of gastric epithelial cell growth by Heticobacter priori: Evidence for a major role of apoptosis
22. Impact of the cyclin-dependent kinase inhibitor p27(kip1) on resistance of tumor ceils to anticancer agents
23. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ
24. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
25. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
26. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
27. Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21(WAF/CIPI) cyclin-dependent kinase inhibitor
28. 1 cyclins
29. WAF1, a potential mediator of p53 tumor suppression
30. 1 cyclin-dependent kinases
31. p27(Kip1), a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
32. 1 cyclin-Cdk protein kinase activity, is related to p21, Cell
33. Cloning of p27(Kip1), a cyclin-Cdk inhibitor and potential mediator of extracellular antimitogenic signals
34. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip1) coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
35. Repression of p27(Kip1) synthesis by platelet-derived growth factor in BALB/c 3T3 cells
36. Translational contrnl of p27(Kip1) accumulation during the cell cycle
37. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
38. 1 arrest is through inhibition of the proteasome independent of hydroxymethyl glutaryl-CoA reductase